We are a drug development company specializing in real pediatric medicine by reformulating compounds currently approved for adults with substantial safety and efficacy and determining an accurate pediatric dosage.
Currently, 70% of the drugs prescribed for children are not approved by the FDA.
Children metabolize drugs more rapidly than adults; our goal is to eliminate the "dosing down" of adult drugs for children based on weight.
Madeira Therapeutics is one of the few drug development companies with a dedicated focus on this niche market-formulations that are sized to fit.
Specialties
pediatric drug medicines, compound, pediatric, Pediatric pharmaceuticals, pharmaceuticals, FDA, FDA-approved, IND, IND approval, drug development, reformulate drug, reformulate compounds, 505(b)(2), drug development company, drug development, biotechnology
